a licensed clinician reviews it and, if you qualify, issues a prescription
Epitalon appears broadly safe for human use, but critical safety testing is lacking even with the peptides relatively long research timeline
The GLOW blend as an injectable preparation should not be used by anyone outside an IRB-approved clinical research study or a licensed provider's specific clinical judgment within a legally permissible 503A compounding pathway
However, by 30 days past the printed date, the same vial could contain as little as 7085% of the original concentration
Tesamorelin should not be used during active malignancy or in pregnancy
Caution is warranted in patients with history of pancreatitis, severe gastrointestinal disease, or gastroparesis